Anyone experiencing their first atrial fibrillation (AFib) episode should go to a hospital. Those with an AFib diagnosis should go if they feel unwell during an episode or have symptoms of a heart ...

The discussion highlighted the potential for CARDAMYST to serve as a first-line treatment for acute PSVT episodes and its possible future application for AFib-RVR in an at-home setting.

and studying atrial fibrillation with rapid ventricular rate (AFib-RVR) in a community setting. The focus of the event was on CARDAMYST (etripamil) nasal spray, Milestone's leading therapeutic ...

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...

The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

An 81-year-old woman with well-controlled hypertension presented to the emergency department with new-onset atrial fibrillation with rapid ventricular response. Treatment for atrial fibrillation was ...